Abdominal Aortic Aneurysm Surgery: Something Old,Something New

Rob CG . Arterial aneurysms: lecture delivered at the Royal College of Surgeons of England. Ann R Coll Surg Engl 1954; 14: 35–49.

Rob C . The sterilization and preservation of homologous arterial segments, with special reference to heart valves. Surgery 1968; 63: 875–6.

Minken SL DeWeese JA Southgate WA Mahoney EB Rob CG . Aortoiliac reconstruction for atherosclerotic occlusive disease. Surg Gynecol Obstet 1968; 126: 1056–60.

Rob C . Four hundred arterial reconstruction operations all followed for more than one and a half years. Minerva Cardioangiol 1960; 8: 31–6.

Brophy CM Reilly JM Smith GJW Tilson MD . The role of inflammation in nonspecific abdominal aortic aneurysm disease. Ann Vasc Surg 1991; 5: 229–33.

Koch AE Haines GK Rizzo RJ Human abdominal aortic aneurysms: immunophenotypic analysis suggesting an immunemediated response. Am J Pathol 1990; 137: 1199–219.

Schmitz-Rixen T Megerman J Colvin RB Immunosuppressive treatment of aortic allografts. J Vasc Surg 1988; 7: 82–92.

Rob CG Eastcott HHG Owen K . The reconstruction of arteries. Br J Surg 1956; 43: 449–66.

Rob C . Arterial homografts. In: Wesolowski SA Dennis C , eds. Fundamentals of Vascular Grafting. New York: McGraw-Hill, 1962: 348–54.

Rob C . Extraperitoneal approach to the abdominal aorta. Surgery 1963; 53: 88–9.

Cambria RP Brewster DC Abbott Transperitoneal versus retroperitoneal approach for aortic reconstruction: a randomized prospective study. J Vasc Surg 1990; 11: 314–25.

Rob CG Williams JP . The diagnosis of aneurysms of the abdominal aorta. (An analysis of 100 patients). J. Cardiovasc Surg (Torino) 1961; 2: 55–60.

Tilson MD Stansel HC . Differences in results for aneurysms vs. occlusive disease after bifurcation grafts: results of 100 elective grafts. Arch Surg 1980; 115: 1173–5.

Vollmar JF Paes E Pauschinger P Henze E Friesch A . Aortic aneurysms as late sequelae of above-knee amputation. Lancet 1989; ii: 834–5.

Paes EH Vollmar JF Pauschinger P Mutschler W Henze E Freisch A . Late vascular damage after unilateral leg amputation. [German] Z Unfallchir Versicherungsmed Berufskr 1990; 83: 227–36.

Tilson MD Newman KM . Proteolytic mechanisms in the pathogenesis of aortic aneurysms. In: Yao JST Pearce W , eds. Aneurysms: New Findings and Treatment. Norwalk, CT: Appleton & Lange, 1994: 3–9.

Kontusaari S Tromp G Kuivaniemi H Romanic A Prockop DJ . A mutation in the gene for Type III procollagen (COL3A1) in a family with aortic aneurysms. J Clin Invest 1990; 86: 1465–73.

Tromp G Wu Y Prockop DJ Sequencing of cDNA from 50 unrelated patients reveals that mutations in the triple-helical domain of Type III procollagen are an infrequent cause of aortic aneurysms. J Clin Invest 1993; 91: 2539–45.

Tilson MD Reilly JM Brophy CM Webster EL Barnett TR . Expression and sequence of the gene for tissue inhibitor of metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg 1993; 18: 266–70.

Kainulainen K Pulkkinen L Savolainen A Kaitila I Peltonen L . Location on chromosome 15 of the gene defect causing Marfan syndrome. N Engl J Med 1990; 323: 935–9.

Dietz HC Pyeritz RE Hall BD The Marfan syndrome locus: confirmation of assignment to chromosome 15 and identification of tightly linked markers at 15q-q21.3. Genomics 1991; 9: 355–61.

Pyeritz RE . Marfan syndrome. N Engl J Med 1990; 323: 987–9.

Sakai LY Keene DR Engvall E . Fibrillin, a new 350-kD glycoprotein component of extracellular microfibrils. J Cell Biol 1986; 103: 2499–509.

Godfrey M Menashe V Weleber RG Cosegregation of elastin-associated microfibrillar abnormalities with the Marfan phenotype in families. Am J Hum Genet 1990; 46: 652–60.

Hollister DW Godfrey M Sakai LY Pyeritz RE . Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome. N Engl J Med 1990; 323: 152–9.

Magenis RE Maslen CL Smith L Localization of the fibrillin (FBN) gene to chromosome 15, band q21.1. Genomics 1991; 11: 346–51.

Maslen CL Corson GM Maddox BK Glanville RW Sakai LY . Partial sequence of a candidate gene for the Marfan syndrome. Nature 1991; 352: 334–7.

Dietz HC Cutting GR Pyeritz RE Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991; 352: 337–9.

Sakai LY Keene DR Glanville RW Bachinger HP . Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils. J Biol Chem 1991; 266: 14763–70.

Spitzer SG Kuppuswamy MN Saini R Kasper CK Birktoft JJ Bajaj SP . Factor IX (Hollywood): substitution of Pro55 by Ala in the first epidermal growth factor-like domain. Blood 1990; 76: 1530–7.

Selander-Sunnerhagen M Ullner M Persson E Teleman O Stenflo J Drakenberg T . How an epidermal growth factor (EFG)-like domain binds calcium. J Biol Chem 1992; 267: 19642–9.

Hanford PA Mayhew M Baron M Winship PR Campbell ID Brownlee GG . Key residues involved in calcium-binding motifs in EGH-like domains. Nature 1991; 351: 164–7.

Milewicz DM Pyeritz RE Crawford ES Byers PH . Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts. J Clin Invest 1992; 89: 79–86.

Dietz HC Saraiva JM Pyeritz RE Cutting GR Francomano CA . Clustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains. Human Mutation 1992; 1: 366–74.

Dietz HC Valle D Francomano CA Kendzior RJ Jr Pyeritz RE Cutting GR . The skipping of constitutive exons in vivo induced by nonsense mutations. Science 1993; 259: 680–2.

Dietz HC Pyeritz RE Puffenberger EG Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene. J Clin Invest 1992; 89: 1674–80.

Lehninger AL Nelson DL Cox MM . Principles of Biochemistry. 2nd edn. Philadelphia: Worth Publishers, 1993: 170.